drugset

drugset / Trial / NCT02528136

The Clinical Carbetocin Myocardium Trial

NCT02528136 ↗

Phase 4 Completed 40 enrolled Oslo University Hospital

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized comparison of different cardiotoxicity of carbetocin and oxytocin.

Timeline

Start: 2015-09
Primary completion: 2019-01-28
Completion: 2019-01-28

Publications

Bekkenes ME, Fagerland MW, Solberg OG, Aaberge L, Klingenberg O, Norseth J, Rosseland LA. Exploring cardiac effects after oxytocin 2.5 IU or carbetocin 100 mug: A randomised controlled trial in women undergoing planned caesarean delivery. Eur J Anaesthesiol. 2022 Dec 1;39(12):928-938. doi: 10.1097/EJA.0000000000001763. Epub 2022 Oct 17.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Carbetocin	Peptide	100 ug	Intravenous
Comparator	Oxytocin	Peptide	2.5 iu	Intravenous

Indications